Wed21
Posted - 18 hours ago
$CDXC looks like they are diluting here. Back to 6 soon.
Wed21
Posted - 22 hours ago
$CDXC offering announced? Strange when they make a profit now. B Riley kicked off it as well lol
Wed21
Posted - 1 day ago
$CDXC they’ve done an offering. No way!
CarpSlayer
Posted - 1 day ago
$CDXC - MetaShape’s PNP inhibitor technology aims to restore NAD+ levels to combat LDL cholesterol, cognitive decline and neurodegeneration. Interesting, if this proves out could make precursors more effective? > "“It appears that NAD precursors, once they get into the intracellular space, are rapidly degraded, and one of the enzymes that degrades them very effectively is PNP,” says Mehrling. “So, our hypothesis was – if we inhibit PNP, then we prevent the degradation, and then supplementing with precursors will enable restoration of the biological system.” https://longevity.technology/news/longevity-biotech-aims-to-unleash-the-power-of-nad-against-age-related-diseases/
PatTheCatdad
Posted - 2 days ago
$BYND nothing's changed since I posted about BYND being my "short squeeze candidate", things have only gotten more constricted... Dec 20 and Jan 17 both continue to have max pains of 11 and 10 with puts still outweighing calls... 11/15 max pain of 7 ended up being an afterthought as the stock just continued to get sold below the 200 day bol band and ever so slightly held underwater where support has been shown on Oct 26th and Aug 5th... Wouldn't be surprised if the stock continues to play within the 5.50 to 6.00 range over the next 2-3 weeks before either: A) shorts cover for a temp relief rally to the 10-11 range for Dec/Jan max pain, before being driven down again towards 5.xx in time for Feb 2025 ER B) shorts cover for a temp relief rally to the 10-11 range, but big tech continues to sell off and market makers look for deep value to rotate into going into 2025, while additional other macro conditions contribute to another 2020-style squeeze (See: $CVNA in 2024) Cheers! $THS $KHC $CDXC
wycliff
Posted - 2 days ago
$CDXC https://search.app/58a5my59TP2rAYGWA we are all anxiously awaiting the results of this trial to see if it helps Parkinson’s patients
CarpSlayer
Posted - 2 days ago
$CDXC - Those who are still valuing this as a strictly dietary supplement company have lost the thread as CDXC begings to dissrupt an already established new market vertical of $100-150M, where they clearly have developed that better mouse trap. There is no established competitor to defeat, just compounders filling orders from clinics that are transitioning to Niage + The best year CDXC ever had in new revenue was 2019 when they generated $14.7 in sales growth. That number could easily be $25-30M in 2025, making CDXC a solidly profitable, cash flow generator with ~30% top line growth. This will play out at about the same time as we get a readout on an important Phase 3 Clinical Trial that could lead to approved drug status in the EU. and a halo effect on Niagen, in any format, in the US. I like my chances.
bosefious
Posted - 2 days ago
$CDXC there is a hard to borrow fee on this now. Hasn’t been one for over a week. More shorts jumping on this. Just FYI
wycliff
Posted - 3 days ago
$CDXC old video but still educational!
wycliff
Posted - 3 days ago
$CDXC Dr.Mehmet Oz who Trump just nominated to run Medicare and Medicaid Services has been on a podcast endorsing Tru-Niagen in the past!
dacrockett02
Posted - 3 days ago
$CDXC The total US Market for IV NAD+ is currently $150 Million annually. IV NR or Niagen plus is expected to completely take over the market. IV NR is cheaper and has a much faster infusion time along with no discomfort. It's not difficult to see why this is up. Pay attention. This alone could get $CDXC over $1/share in earnings. Not to mention the other growth verticals. Short at your own peril.
bosefious
Posted - 3 days ago
$CDXC 400 p/e. Reading through all of the news articles, this is hyped by social media influencers, human trials which prove to be safe, only short term use though, NAD levels increasing, but no noted actual benefits. This could have potential if all prevails, who doesn’t want the “fountain of youth” drug. Smells sus though and overhyped currently. I’m currently short, I’ve been wrong before, but just be careful buying high right now.
NightStocker520
Posted - 3 days ago
$CDXC Sumptins up?
wycliff
Posted - 3 days ago
$CDXC
Wed21
Posted - 3 days ago
$CDXC price movement on 300k shares lol. See this bleeding down soon. No profit takers but no buyers as it stands.
Innerprize
Posted - 3 days ago
$CDXC NIAGEN study-- NAD+ activates renal metabolism and protects from chronic kidney disease in a model of Alport syndrome https://www.biorxiv.org/content/10.1101/2024.02.26.580911v2